General Information of Drug (ID: DM4RTJJ)

Drug Name
BMS-986277
Indication
Disease Entry ICD 11 Status REF
Carcinoma 2A00-2F9Z Phase 1/2 [1]
Cross-matching ID
TTD ID
D0T8JY

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)